Hamilton James C's Form 4 filing
Arrowhead Pharmaceuticals, Inc. (ARWR) · filed Jan 5, 2026
- Accession no.
- 0001830755-26-000002
- Filed
- Jan 5, 2026
- Trade date
- Jan 5, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.53M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hamilton James CCIK 0001830755 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | Common Stock | SSaleDisposed | −4,625 | $61.24 | −$283,235 | 207,497 | Direct | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −6,090 | $62.28 | −$379,285.2 | 201,407 | Direct | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −14,792 | $63.01 | −$932,043.92 | 186,615 | Direct | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −12,711 | $63.95 | −$812,868.45 | 173,904 | Direct | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −1,200 | $64.49 | −$77,388 | 172,704 | Direct | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −437 | $65.97 | −$28,828.89 | 172,267 | Direct | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −309 | $68.00 | −$21,012 | 171,958 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.